Marshall Wace LLP Purchases Shares of 44,509 Relx Plc (NYSE:RELX)

Marshall Wace LLP purchased a new stake in Relx Plc (NYSE:RELX) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 44,509 shares of the technology company’s stock, valued at approximately $1,187,000.

Other large investors have also bought and sold shares of the company. Red Door Wealth Management LLC purchased a new stake in Relx in the second quarter valued at $25,000. Advisory Services Network LLC purchased a new stake in Relx in the second quarter valued at $33,000. Lumature Wealth Partners LLC boosted its holdings in Relx by 14.3% in the second quarter. Lumature Wealth Partners LLC now owns 2,786 shares of the technology company’s stock valued at $74,000 after purchasing an additional 348 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of Relx by 421.1% during the 2nd quarter. Bessemer Group Inc. now owns 3,627 shares of the technology company’s stock worth $97,000 after acquiring an additional 2,931 shares in the last quarter. Finally, Toronto Dominion Bank boosted its stake in shares of Relx by 38.0% during the 2nd quarter. Toronto Dominion Bank now owns 3,980 shares of the technology company’s stock worth $106,000 after acquiring an additional 1,095 shares in the last quarter. 5.98% of the stock is currently owned by institutional investors.

RELX has been the topic of several recent analyst reports. Societe Generale reissued a “buy” rating on shares of Relx in a research note on Monday, August 2nd. Barclays restated an “overweight” rating on shares of Relx in a research report on Friday, October 22nd. Zacks Investment Research downgraded shares of Relx from a “hold” rating to a “sell” rating in a research report on Wednesday, October 13th. Credit Suisse Group restated an “outperform” rating on shares of Relx in a research report on Thursday, October 7th. Finally, JPMorgan Chase & Co. restated an “overweight” rating on shares of Relx in a research report on Friday, July 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $33.00.

RELX stock opened at $31.27 on Thursday. The company has a current ratio of 0.53, a quick ratio of 0.46 and a debt-to-equity ratio of 2.50. Relx Plc has a 12 month low of $23.18 and a 12 month high of $32.04. The firm has a 50-day moving average of $30.58 and a two-hundred day moving average of $29.05.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also: Book Value Per Share – BVPS

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.